单抗血小板治疗与双抗血小板治疗在表面修饰血流导向装置治疗颅内动脉瘤中的比较:系统综述与meta分析

系统综述与meta分析数据集,比较单抗与双抗在表面修饰血流导向装置治疗颅内动脉瘤中的疗效和安全性。

figsharefigshare
DataCite Commons
2025-08-26 更新
浏览 14
表格intracranial aneurysms (IA)flow diverter stentssurface modification impacts changesantiplatelet therapy (APT)MetaAnalysis
Comparison of Single Antiplatelet Therapy and Dual Antiplatelet Therapy in the Treatment of Intracranial Aneurysms with Surface-modified Flow Diverters: a Systematic Review and Meta-analysis

基本信息

模态
表格
大小
0.024148431 GB
许可
CC BY 4.0
创建/更新时间
2025-08-26
版本
v6

资源简介

单抗血小板治疗与双抗血小板治疗在表面修饰血流导向装置治疗颅内动脉瘤中的比较:系统综述与meta分析

【一句话概览】

本数据集是 figshare 公开的结构化表格数据集,收录 21 个文件、合计 24.15 MB,主题涵盖 intracranial aneurysms (IA)、flow diverter stents、surface modification impacts changes、antiplatelet therapy (APT)、MetaAnalysis,可用于统计建模、特征工程与队列分析,CC BY 4.0 许可开放获取。

【数据集背景】

本数据集源站标题为《Comparison of Single Antiplatelet Therapy and Dual Antiplatelet Therapy in the Treatment of Intracranial Aneurysms with Surface-modified Flow Diverters: a Systematic Review and Meta-analysis》。源站首次发布:2025-08-26。

【数据内容】

源站原始描述:Objective: Surface-modified flow diverters (SMFDs) enable application of single antiplatelet therapy (SAPT) for intracranial aneurysms (IAs) treatment. This study systematically evaluated the feasibility of SAPT as an alternative to dual antiplatelet therapy (DAPT). Methods: PubMed, Scopus, and Web of Science were searched for SMFD studies. Two reviewers independently assessed eligibility. Study quality was evaluated using NIH tools and Egger’s test. Outcomes were pooled via Freeman-Tukey arcsin…

中文译文(机器翻译,仅供快速理解,请以原文为准):目的:表面修饰血流导向装置(SMFDs)使单一抗血小板治疗(SAPT)可用于颅内动脉瘤(IAs)治疗。本研究系统评价了SAPT作为双联抗血小板治疗(DAPT)替代方案的可行性。 方法:检索PubMed、Scopus和Web of Science中关于SMFD的研究。两名评价者独立评估纳入资格。采用NIH工具和Egger检验评价研究质量。通过Freeman-Tukey反正弦转换合并结局,采用I²评估异质性。 结果:分析纳入6项SAPT研究(200例患者

【数据结构与技术规格】

文件数 21 个,合计 24.15 MB。Supplemental Figure 1.jpg:image/jpeg,1.38 MB。Supplemental Figure 2.jpg:image/jpeg,3.18 MB。Supplemental Figure 3.jpg:image/jpeg,1.14 MB。数据集 DOI:10.6084/m9.figshare.28689434.v6。

【主题与分类】

源站学科分类:Other health sciences not elsewhere classified。主题标签:intracranial aneurysms (IA)、flow diverter stents、surface modification impacts changes、antiplatelet therapy (APT)、MetaAnalysis。

【适用方向】

结构化表格数据可直接用于统计建模、特征工程与队列分析。

【获取与许可】

源站页面:https://figshare.com/articles/dataset/_b_Comparison_of_b_b_Single_Antiplatelet_Therapy_b_b_and_b_b_Dual_Antiplatelet_Therapy_b_b_in_the_Treatment_of_Intracranial_Aneurysms_with_Surface-modified_Flow_Diverters_b_b_a_Systematic_Review_and_Meta-analysis_b_Item/28689434

使用许可:CC BY 4.0(https://creativecommons.org/licenses/by/4.0/)。

规范引用:Wang, Xinyu (2025). Comparison of Single Antiplatelet Therapy and Dual Antiplatelet Therapy in the Treatment of Intracranial Aneurysms with Surface-modified Flow Diverters: a Systematic Review and Meta-analysis. figshare. Dataset

官方服务

专家保障全链路合规授权与标注交付

陕川双基地 × 超十家三甲医院直连

从合规授权、采集治理、专业标注到数据集交付,我们提供全链路闭环服务,让高质量临床数据即拿即用。

⚡️ 需要原始数据或标注支持?联系我们获取定制方案。

帮我联系

下载信息

注册下载

需要注册 Kaggle 账号并登录后下载,适合需要跟踪下载记录和使用 API 的用户。

暂未开放

公开下载

无需注册即可直接获取公开样本或文档,适合快速预览和评估数据集质量。

免登录

有偿下载

公开数据集受托下载与技术交付服务。

提供高速下载与技术交付服务(收技术服务费,非数据销售)

暂未开放

当前数据集主要来源为 Kaggle 公开托管,完整影像包建议通过原始链接或 Kaggle API 获取。

使用方式

数据集获取(Figshare)

命令行下载

curl -L -o "Supplemental Figure 1.jpg" "https://ndownloader.figshare.com/files/57440836"
curl -L -o "Supplemental Figure 2.jpg" "https://ndownloader.figshare.com/files/57440839"
curl -L -o "Supplemental Figure 3.jpg" "https://ndownloader.figshare.com/files/57440842"
curl -L -o "Supplemental Figure 4.jpg" "https://ndownloader.figshare.com/files/57440845"
curl -L -o "Supplemental Figure 5.jpg" "https://ndownloader.figshare.com/files/57440848"
curl -L -o "Supplemental Figure 6.jpg" "https://ndownloader.figshare.com/files/57440851"
curl -L -o "Supplemental Figure 7.jpg" "https://ndownloader.figshare.com/files/57440854"
curl -L -o "Supplemental Figure 8.jpg" "https://ndownloader.figshare.com/files/57440857"

文件清单

  • Supplemental Figure 1.jpg(1.38 MB)
  • Supplemental Figure 2.jpg(3.18 MB)
  • Supplemental Figure 3.jpg(1.14 MB)
  • Supplemental Figure 4.jpg(1.84 MB)
  • Supplemental Figure 5.jpg(4.39 MB)
  • Supplemental Figure 6.jpg(2.08 MB)
  • Supplemental Figure 7.jpg(3.51 MB)
  • Supplemental Figure 8.jpg(2.06 MB)
  • Supplemental Figure 9.jpg(2.45 MB)
  • Supplemental Figure 10.jpg(1.95 MB)
  • Supplemental Table 1.xlsx(14.66 KB)
  • Supplemental Table 2.xlsx(16.80 KB)
  • Supplemental Table 3.xlsx(11.81 KB)
  • Supplemental Table 4.xlsx(16.16 KB)
  • Supplemental Table 5.xlsx(12.53 KB)
  • Supplemental Table 6.xlsx(14.11 KB)
  • Supplemental Table 7.xlsx(22.62 KB)
  • Supplemental Table 8.xlsx(9.92 KB)
  • Supplemental Table 9.xlsx(14.40 KB)
  • Supplemental Table 10.xlsx(11.52 KB)

文件总体积 24.15 MB(源站 API 实测)。

数据说明

Objective: Surface-modified flow diverters (SMFDs) enable application of single antiplatelet therapy (SAPT) for intracranial aneurysms (IAs) treatment. This study systematically evaluated the feasibility of SAPT as an alternative to dual antiplatelet therapy (DAPT).
Methods: PubMed, Scopus, and Web of Science were searched for SMFD studies. Two reviewers independently assessed eligibility. Study quality was evaluated using NIH tools and Egger’s test. Outcomes were pooled via Freeman-Tukey arcsine transformation, with heterogeneity assessed by I².
Results: The analysis included 6 SAPT studies (200 patients, 243 aneurysms) and 18 DAPT studies (1553 patients, 1728 aneurysms). All efficacy and safety outcomes—including 6-month complete occlusion rates (77.1% vs 72.2%), 6-month adequate occlusion rates (86.9% vs 86.6%), all-cause mortality (0.2% vs 0.3%), treatment-related mortality (0% vs 0.1%), morbidity (0% vs 0.4%), ischemic complications (1.7% vs 4.6%), thrombosis formation (1.3% vs 2.3%), and intracranial hemorrhage rates (0% vs 0.9%)—exhibited no significant differences. For p48/64 HPC specifically, the remaining outcomes also exhibited no significant differences, with the exception of lower 6-month adequate occlusion rates in the SAPT group (85.5% vs 93.8%, P = .03). Compared to prasugrel monotherapy and DAPT regimens, aspirin was more economical yet poses higher safety risk.
Limitations: Limitations include the limited sample size of the SAPT group, the retrospective design of most included studies, and significant heterogeneity.
Conclusions: SAPT shows comparable efficacy and safety to DAPT. Prasugrel monotherapy is a more preferable option compared with aspirin. SAPT may be a viable alternative, particularly for high-hemorrhage-risk patients.

许可

CC BY 4.0

引用

学术使用请引用 DOI 10.6084/m9.figshare.28689434.v6(source: https://figshare.com/articles/dataset/_b_Comparison_of_b_b_Single_Antiplatelet_Therapy_b_b_and_b_b_Dual_Antiplatelet_Therapy_b_b_in_the_Treatment_of_Intracranial_Aneurysms_with_Surface-modified_Flow_Diverters_b_b_a_Systematic_Review_and_Meta-analysis_b_Item/28689434)。

数据缺失?

依托陕西、四川两大基地,我们与超过十家三甲医院建立直接合作关系,覆盖合规授权、采集治理、专业标注、数据交付的全流程,为AI医疗团队提供即拿即用的高质量临床数据。

⚡️ 需要数据支持或标注服务?立即联系我们获取专业方案。

获取专属数据定制方案